Pilot and Feasibility Program The purpose of the Pilot and Feasibility Program (PFP) of the Washington University Diabetes Research Center (DRC) is to provide, on a modest scale: (1) initial support for new investigators who do not yet have their own peer-reviewed research support, (2) support for established investigators from other fields of investigation to apply their expertise to diabetes-related research, and (3) support for established investigators in diabetes embarking on an entirely new direction of research. An important goal of the PFP is to allow these investigators to develop preliminary data sufficient to provide the basis for subsequent applications for independent extramural research support. Following an annual competition, awards of up to $50,000 are made to independent faculty level investigators with the potential for renewal for a second year contingent on demonstrated progress. Grant applicants and recipients are mentored by the PFP Director and DRC Co- Director, Dr. Clay Semenkovich. A total of $250,000 of the annual DRC budget is committed to the PFP, to which substantial institutional support is added. Since 2012, the PFP has supported 35 new projects, 26 of which were awarded to new investigators and 2 of which were awarded to early stage investigators. PFP support during the last funding cycle led to 13 NIH and 4 foundation grants and 49 publications. Thus, the PFP has been a highly productive component of the DRC with an emphasis on mentoring and funding young faculty.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Saint Louis
United States
Zip Code
Tuttle, Lori J; Bittel, Daniel C; Bittel, Adam J et al. (2018) Early-Onset Physical Frailty in Adults With Diabesity and Peripheral Neuropathy. Can J Diabetes 42:478-483
Song, Wilbur M; Joshita, Satoru; Zhou, Yingyue et al. (2018) Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J Exp Med 215:745-760
Musselman, Laura Palanker; Fink, Jill L; Maier, Ezekiel J et al. (2018) Seven-Up Is a Novel Regulator of Insulin Signaling. Genetics 208:1643-1656
Riek, Amy E; Oh, Jisu; Darwech, Isra et al. (2018) Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes. J Steroid Biochem Mol Biol 177:187-192
Peterson, Linda R; Xanthakis, Vanessa; Duncan, Meredith S et al. (2018) Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. J Am Heart Assoc 7:
Bittel, Adam J; Bohnert, Kathryn L; Reeds, Dominic N et al. (2018) Reduced Muscle Strength in Barth Syndrome May Be Improved by Resistance Exercise Training: A Pilot Study. JIMD Rep :
Hampton, Kaia K; Anderson, Katie; Frazier, Hilaree et al. (2018) Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1. Mol Pharmacol 94:665-673
Ferguson, Daniel; Blenden, Mitchell; Hutson, Irina et al. (2018) Mouse Embryonic Fibroblasts Protect ob/ob Mice From Obesity and Metabolic Complications. Endocrinology 159:3275-3286
Samovski, Dmitri; Dhule, Pallavi; Pietka, Terri et al. (2018) Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling. Diabetes 67:1272-1284
Warren, Junco S; Tracy, Christopher M; Miller, Mickey R et al. (2018) Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart. Proc Natl Acad Sci U S A 115:E7871-E7880

Showing the most recent 10 out of 654 publications